Bangla DOM Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Bangla DOM Pharmaceutical Export Portfolio Dataset — 2 Products, $36.5K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Bangla DOM — Pharmaceutical Exporter Profile (2026) | 2 Products, $36.5K Trade | TransData Nexus

Bangla DOM

Indian Pharmaceutical Exporter · Ayurvedic & Herbal Products Specialist · $36.5K Total Trade · DGFT Verified

Bangla DOM is an Indian pharmaceutical exporter with a total trade value of $36.5K across 2 products in 1 therapeutic categories. Based on 144 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Kwatha ($32.6K), Gutika ($3.9K), .

Bangla DOM — Export Portfolio & Destination Treemap

Bangla DOM pharmaceutical export portfolio — 2 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Bangla DOM? — Company Overview & Market Position

Bangla DOM is a proprietary firm based in New Delhi, India, specializing in the wholesale trade of Ayurvedic and herbal pharmaceutical products. Established on August 12, 2021, the company operates under the UDYAM Registration system with the number UDYAM-DL-01-0009449, classifying it as a micro enterprise for the fiscal year 2025-26. The firm's registered address is 2325-26-B, Ground Floor, Tilak Street, Chuna Mandi, Paharganj, New Delhi, Delhi - 110055. As a micro enterprise, Bangla DOM benefits from various government schemes and initiatives designed to support small and medium businesses in India. The company has maintained its micro enterprise status since April 1, 2025, reflecting consistent growth and compliance with MSME regulations.

What Does Bangla DOM Export? — Product Portfolio Analysis

Top Products by Export Value

1Kwatha$32.6K 2Gutika$3.9K

Bangla DOM Therapeutic Categories — 1 Specializations

Product Portfolio — Top 2 by Export Value

Bangla DOM exports 2 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Kwatha	Ayurvedic & Herbal Products	$32.6K	134	6.1%	4
2	Gutika	Ayurvedic & Herbal Products	$3.9K	10	3.1%	8

Bangla DOM exports 2 pharmaceutical products across 1 therapeutic categories with a total export value of $36.5K. The top category is Ayurvedic & Herbal Products (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Bangla DOM — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Specific details regarding Bangla DOM's manufacturing facilities, including locations, capacities, and specializations, are not publicly available. The company's focus on wholesale trade suggests that it may not operate its own manufacturing plants but instead sources products from third-party manufacturers. This approach is common among wholesale distributors, allowing them to offer a diverse product range without the overhead associated with manufacturing operations.

3Key Leadership

Information about the key leadership team at Bangla DOM, including the CEO, CFO, and other executives, is not publicly disclosed. The company's proprietary nature and limited public presence may contribute to the lack of available information regarding its leadership structure.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Bangla DOM Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Bangla DOM's export activities are primarily focused on Ayurvedic and herbal pharmaceutical products, with a total export value of $37,000 USD across 144 shipments. The company's top two products, Kwatha and Gutika, have market shares of 6.1% and 3.1%, respectively. The primary therapeutic category for these products is Ayurvedic & Herbal Products, indicating a niche focus within the pharmaceutical industry. Given the specialized nature of Ayurvedic products, Bangla DOM's presence in highly regulated markets such as the US, EU, UK, Australia, and Japan would require adherence to stringent regulatory standards, including obtaining necessary approvals and certifications. However, specific details regarding regulatory filings, approvals, and market access status in these regions are not publicly available.

2Emerging Markets

Bangla DOM's export data indicates shipments to various countries, including Uzbekistan, suggesting an interest in emerging markets. The company's focus on Ayurvedic and herbal products aligns with the growing global demand for natural and alternative medicines. While specific information about WHO prequalification or other certifications enabling access to these markets is not available, obtaining such certifications would be crucial for expanding into regions with developing healthcare infrastructures.

Geographic Strategy

Bangla DOM — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Bangla DOM's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. Given the company's focus on Ayurvedic and herbal products, it is likely that their products are marketed as dietary supplements rather than conventional pharmaceuticals, which may not require FDA approval. However, if Bangla DOM intends to market its products as drugs in the U.S., obtaining FDA approvals and complying with regulatory requirements would be essential.

2WHO & EU GMP

Information regarding Bangla DOM's WHO prequalification, EU Good Manufacturing Practice (GMP) certificates, or European Directorate for the Quality of Medicines & HealthCare (EDQM) status is not publicly available. Given the company's focus on Ayurvedic and herbal products, obtaining such certifications would be beneficial for expanding into international markets that require adherence to stringent quality standards.

3CDSCO & Indian Regulatory

Bangla DOM — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Bangla DOM operates in the niche market of Ayurvedic and herbal pharmaceutical products, with a total export value of $37,000 USD across 144 shipments. The company's top two products, Kwatha and Gutika, have market shares of 6.1% and 3.1%, respectively. The primary therapeutic category for these products is Ayurvedic & Herbal Products, indicating a specialized focus within the pharmaceutical industry. While specific information about competitors in this niche market is not available, the growing global demand for natural and alternative medicines suggests a competitive landscape with both local and international players.

2Key Differentiators

Bangla DOM's focus on Ayurvedic and herbal pharmaceutical products allows it to cater to the growing global demand for natural and alternative medicines. The company's export data indicates shipments to various countries, including Uzbekistan, suggesting an interest in emerging markets. This geographic diversification strategy enables Bangla DOM to tap into new markets and mitigate risks associated with overreliance on a single market.

3Strategic Position

Buyer Due Diligence Brief — Evaluating Bangla DOM as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Specific details regarding Bangla DOM's suppliers are not publicly available. The company's focus on wholesale trade suggests that it sources products from third-party manufacturers. Given the specialized nature of Ayurvedic and herbal products, it is essential for Bangla DOM to collaborate with suppliers who adhere to stringent quality standards and regulatory requirements. While specific information about the company's suppliers is not available, the growing global demand for natural and alternative medicines suggests a competitive landscape with both local and international suppliers.

2Certifications to Verify

Importers should verify the following certifications when considering products from Bangla DOM:

FDA Approval: To ensure compliance with U.S. regulations, verify that the products are registered with the FDA. This can be done by checking the FDA's online databases or contacting the FDA directly.

WHO-GMP Certification: To confirm adherence to international manufacturing standards, verify that the products are manufactured in facilities with WHO-GMP certification. This information can typically be obtained from the manufacturer or through the World Health Organization's official channels.

Frequently Asked Questions — Bangla DOM

How many pharmaceutical products does Bangla DOM export from India?

Bangla DOM exports 2 pharmaceutical products across 1 therapeutic categories. The top exports are Kwatha ($32.6K), Gutika ($3.9K). Total export value is $36.5K.

What is Bangla DOM's total pharmaceutical export value?

Bangla DOM's total pharmaceutical export value is $36.5K, based on 144 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Bangla DOM cover?

Bangla DOM exports across 1 therapeutic categories. The largest are Ayurvedic & Herbal Products (100.0%, 2 products).

Get Full Bangla DOM Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.